Aditx, Inc. (ADTX)

NASDAQ: ADTX · IEX Real-Time Price · USD
1.64
-0.03 (-1.80%)
At close: Dec 9, 2022 4:00 PM
1.67
+0.03 (1.83%)
After-hours: Dec 9, 2022 5:42 PM EST
-1.8%
Market Cap 7.03M
Revenue (ttm) 853,153
Net Income (ttm) -43.52M
Shares Out 1.43M
EPS (ttm) -1.72
PE Ratio n/a
Forward PE 0.37
Dividend n/a
Ex-Dividend Date Sep 14, 2022
Volume 42,937
Open 1.67
Previous Close 1.67
Day's Range 1.61 - 1.67
52-Week Range 1.57 - 41.15
Beta 1.37
Analysts Buy
Price Target 27.54 (+1,579.3%)
Earnings Date Nov 21, 2022

About ADTX

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ trans... [Read more]

Industry Biotechnology
IPO Date Jun 30, 2020
Employees 58
Stock Exchange NASDAQ
Ticker Symbol ADTX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for ADTX stock is "Buy." The 12-month stock price forecast is 27.54, which is an increase of 1,579.27% from the latest price.

Price Target
$27.54
(1,579.27% upside)
Analyst Consensus: Buy
Stock Forecasts

News

FedEx Features AditxtScore™ Immune Monitoring Center and its Service in Richmond, VA, Highlighting the Importance of ...

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc.'s (NASDAQ: ADTX) (“Aditxt”, or the “Company”) AditxtScore™ is featured by FedEx in a video presentation that showcases the various ways in which both compani...

2 months ago - Business Wire

Is the Options Market Predicting a Spike in Aditx (ADTX) Stock?

Investors need to pay close attention to Aditx (ADTX) stock based on the movements in the options market lately.

2 months ago - Zacks Investment Research

Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulatin...

2 months ago - Business Wire

Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the...

2 months ago - Business Wire

Aditxt Announces Closing of $20.0 Million Public Offering

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc., (Nasdaq: ADTX) (the “Company” or “Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating th...

2 months ago - Business Wire

Aditxt Announces Pricing of $20.0 Million Public Offering

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc., (Nasdaq: ADTX) (the “Company” or “Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating th...

2 months ago - Business Wire

What Is Going on With Aditxt (ADTX) Stock Today?

Source: motorolka / Shutterstock.com Aditxt (NASDAQ: ADTX ) stock is in the spotlight after the company implemented a reverse stock split yesterday. Down 16% as of this writing, today's movement in ADTX...

2 months ago - InvestorPlace

Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, announced to...

2 months ago - Business Wire

Why Is Aditxt (ADTX) Stock Up 74% Today?

ADTX stock is soaring after the company reported positive results from a preclinical toxicology test this morning. The post Why Is Aditxt (ADTX) Stock Up 74% Today?

5 months ago - InvestorPlace

Why Aditxt Shares Are Rallying Today?

Aditxt Inc's (NASDAQ: ADTX) therapeutic program Adimune has completed a toxicology study indicating a favorable safety profile of ADI-100 for rejection of transplanted organs, skin allografting, autoimm...

5 months ago - Benzinga

Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100 Advancing it ...

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the "Company"), a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming ...

5 months ago - Business Wire

Premier Medical Laboratory Services Now Offering AditxtScore™ Personalized Immune Test for COVID-19

GREENVILLE, S.C. , June 14, 2022 /PRNewswire/ -- Premier Medical Laboratory Services (PMLS), a nation leading advanced medical diagnostics lab, adds AditxtScore™ to its menu of testing services.

5 months ago - PRNewsWire

ADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates Aditxt, Inc. - ADTX

CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of AiPharma Group Ltd. to Aditxt, Inc. (“the Company”) (NasdaqCM: ADTX). Under the terms of the proposed transacti...

7 months ago - Business Wire

Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore™ to Accel...

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (“Aditxt”, or the “Company”) (Nasdaq: ADTX), a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, tod...

7 months ago - Business Wire

Aditxt to Participate in the 2022 Virtual Growth Conference

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, announced today that Company CEO...

8 months ago - Business Wire

ADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates Adequacy of Price and Process in Proposed Sale of Aditxt, Inc....

CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of AiPharma Group Ltd. to Aditxt, Inc. (“the Company”) (NasdaqCM: ADTX). Under the terms of the proposed transacti...

8 months ago - Business Wire

ADITXT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Aditxt, Inc. -...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AiPharma Group Ltd...

9 months ago - Business Wire

Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure ...

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (“Aditxt,” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to advance humanity's transition to the “Age of Immunity,” has submi...

10 months ago - Business Wire

Aditxt, Inc. to Participate in Edison Group's Global Healthcare “Open House” Virtual Conference From January 25th-27t...

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX) announced today it is participating in Edison Group's Open House Event, scheduled to take place virtually this mon...

10 months ago - Business Wire

Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it will h...

10 months ago - Business Wire

SHAREHOLDER ALERT: WeissLaw LLP Investigates Aditxt, Inc.

NEW YORK, Dec. 29, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aditxt, Inc. ("Aditxt" or the "Company"...

11 months ago - PRNewsWire

Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it had si...

11 months ago - Business Wire

Aditxt (ADTX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Aditxt Inc. Is...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Aditxt Inc. (NASDAQ: ADTX) and AiPharma Global Holdings LLC is fair to Aditxt share...

11 months ago - Business Wire